Gene Expression Ratios Lead to Accurate and Translatable Predictors of DR5 Agonism across Multiple Tumor Lineages
Death Receptor 5 (DR5) agonists demonstrate anti-tumor activity in preclinical models but have yet to demonstrate robust clinical responses. A key limitation may be the lack of patient selection strategies to identify those most likely to respond to treatment. To overcome this limitation, we screene...
Main Authors: | Reddy, Anupama, Growney, Joseph D., Wilson, Nick S., Emery, Caroline M., Johnson, Jennifer A., Ward, Rebecca, Monaco, Kelli A., Korn, Joshua, Monahan, John E., Stump, Mark D., Mapa, Felipa A., Wilson, Christopher J., Steiger, Janine, Ledell, Jebediah, Rickles, Richard J., Myer, Vic E., Ettenberg, Seth A., Schlegel, Robert, Sellers, William R., Huet, Heather A., Lehár, Joseph |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574744/ |
Similar Items
-
Correction: Gene Expression Ratios Lead to Accurate and Translatable Predictors of DR5 Agonism across Multiple Tumor Lineages
by: Reddy, Anupama, et al.
Published: (2016) -
Agonizing Hedgehog
by: Weitzman, Jonathan B
Published: (2002) -
Agonism and Antagonism at the Insulin Receptor
by: Knudsen, Louise, et al.
Published: (2012) -
A Pharmacological Primer of Biased Agonism
by: Andresen, Bradley T
Published: (2011) -
Inverse agonism and its therapeutic significance
by: Khilnani, Gurudas, et al.
Published: (2011)